ZBH: Bull Flag detected on 26 Aug 2026

Zimmer Biomet is forming a bull flag pattern following recent strength, with the stock currently at 100.24, positioned between key support at 98.67 and resistance at 101.95. Pattern structure scores 14.2/15, breakout quality 11.0/13, and volume confirmation 12.0/12, yielding an overall score of 72.2/98. The setup suggests a relatively clean consolidation with strong technical confirmation. RSI at 59.31 indicates room to run without overbought conditions. Win probability registers 74.49%, supported by previous patterns: an ascending triangle (45 days, score 30.0) and a cup-handle (250 days, score 20.5). Volume ratio of 0.53 reflects below-average current participation, typical in flag formation phases.

Zimmer Biomet released Q2 2026 earnings on August 5th, reporting EPS of $2.07, beating estimates of $2.03 by $0.04. Revenue reached $2.18 billion, up 4.8% year-over-year, with the company raising full-year guidance. Management highlighted momentum from new products and an ongoing U.S. sales force transformation, driven by stronger hip and technology segment performance. The company increased planned share repurchases to $1 billion for fiscal 2026, a $250 million increase from prior guidance, signaling management confidence. Adjusted EPS guidance was raised to $8.40–8.55 from $8.30–8.45. However, institutional activity is mixed: 368 investors added shares while 414 decreased positions in the most recent quarter, suggesting institutional sentiment remains cautious despite earnings strength.

A successful bull flag breakout would target 103.55 (conservative target), requiring sustained volume confirmation above the 101.95 resistance level. Historical data indicates 74.49% win probability for this pattern type. The flag suggests a measured move of approximately 2.88% from breakout point, with invalidation occurring if price closes below key support at 98.67—a 1.57% downside risk. Beta of 0.59 indicates lower volatility than the broad market, which may constrain explosive upside acceleration but provides stability. Volume confirmation is critical; current relative volume of 0.53 suggests participation could strengthen during breakout confirmation.

Insider selling activity presents a caution flag: Over the past six months, insiders have traded 4 times, with 0 purchases and 4 sales. Price T Rowe Associates removed 5.6 million shares (-41.3%) in Q1 2026, indicating significant institutional exits. Analyst price targets average $98.70, below current price of 100.24, creating limited upside consensus. The healthcare sector faces regulatory scrutiny and reimbursement pressure not explicitly detailed in recent news. Valuation concerns persist despite positive earnings—the stock has declined 27.9% over five years despite operational improvements, suggesting structural headwinds. No imminent earnings catalyst until Q3 2026 results, reducing near-term fundamental support for a sustained breakout.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.